MARKET

NTRB

NTRB

Nutriband Inc
NASDAQ
3.310
-0.050
-1.49%
After Hours: 3.560 +0.25 +7.55% 16:10 03/31 EDT
OPEN
3.270
PREV CLOSE
3.360
HIGH
3.400
LOW
3.270
VOLUME
6.19K
TURNOVER
0
52 WEEK HIGH
6.98
52 WEEK LOW
2.409
MARKET CAP
25.93M
P/E (TTM)
-4.3952
1D
5D
1M
3M
1Y
5Y
Pre-market Movers: VKTX, IMRX, OSCR, WISA, ITCI…
NASDAQ · 4d ago
Nutriband Secured $2M Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
Benzinga · 5d ago
BHC, ONVO and AMAM among healthcare gainers
Seeking Alpha · 02/15 16:09
Nutriband To File for Product Distribution Permit In South America With Ecuador's Health Register
Benzinga · 02/15 11:05
Nutriband to Begin Trading on Upstream App
Nutriband to Begin Trading on Upstream App
MT Newswires · 01/05 06:55
Nutriband Inc. To Dual List On Upstream
Benzinga · 12/30/2022 11:32
Nutriband Begins Production of AI Tape Brand, Launch Expected in Q1
Nutriband Begins Production of AI Tape Brand, Launch Expected in Q1
MT Newswires · 12/29/2022 07:10
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
RedChip Companies will air a new interview with Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) on The RedChip Money Report® on Bloomberg TV this Saturday, December 17, at 7 p.m. Eastern Time (ET).
ACCESSWIRE · 12/14/2022 11:00
More
About NTRB
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. The Company's lead product is its AVERSA technology, an abuse deterrent technology that can be incorporated into any transdermal patch to deter the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. Its first product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an existing generic fentanyl patch with its AVERSA technology to reduce the abuse and misuse of fentanyl patches. It is also focused on the development of additional products utilizing the AVERSA abuse deterrent transdermal technology, which include AVERSA Buprenorphine and AVERSA Methylphenidate. In addition, it is developing a portfolio of transdermal pharmaceutical products to deliver commercially available drugs or biologics that are typically delivered by injection. Its subsidiaries include 4P Therapeutics LLC and Pocono Pharmaceuticals Inc.

Webull offers kinds of Nutriband Inc stock information, including NASDAQ:NTRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTRB stock methods without spending real money on the virtual paper trading platform.